Food as the Main Travel Agenda: Travellers Plan Trips Around Gastronomic Experiences this Valentine’s Day
Food becomes a central purpose for travel, with food-related bookings up by 43% YoY and surge in fine-dining interest Gastronomic hubs such as Bangkok, Seoul... Read more.
CCT Names Sherry Stewart Vice President of Finance
TULSA, Okla., Feb. 11, 2026 /PRNewswire/ — In fast-growing companies, there is a moment when momentum changes the stakes. The business keeps moving, and every... Read more.
12Port to Showcase AI-Powered Session Intelligence for Modern Privileged Access Management at RSAC 2026
The 12Port Agentless PAM Platform helps enterprises operationalize Zero Trust with smarter access, intelligent insight, and faster response. EXTON, Penn., Feb. 11,... Read more.
EDB CEO: The AI Platform Race Is Accelerating, and Sovereign Control Will Separate Winners in 2026
As OpenAI bets on Postgres® and Snowflake moves to bypass traditional cloud gatekeepers, Kevin Dallas asserts that nearly one-third of the market will reach “escape... Read more.
Heven AeroTech Extends DoW HyTEC Work With New Contract For Hydrogen Generation Trailer
STERLING, Va., Feb. 11, 2026 /PRNewswire/ — Zepher Flight Labs, a subsidiary of Heven AeroTech, a U.S.-based pioneer of hydrogen-powered, long-endurance unmanned... Read more.
“Uncommon Sense”: A Hands-On Guide to Thriving in the Wild West of Business by Mel Blackwell
“Business truly is like the Wild West. It doesn’t matter what a business’s website says or how nice their lobby smells. The true test is what’s... Read more.
Constructive Launches Secure-by-Default Postgres Platform for the Agentic Era
The team behind 100M+ open-source downloads unveils a secure Postgres platform that compiles Row-Level Security at table creation. SAN FRANCISCO, Feb. 11, 2026 /PRNewswire/... Read more.
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
NEW YORK, Feb. 11, 2026 /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a... Read more.
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook
SEATTLE, Feb. 11, 2026 /PRNewswire/ — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical... Read more.
Cryoport’s MVE Biological Solutions Introduces New Fusion® 800 Series
Self-Sustaining Fusion® 800 Series Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, and Cost Benefits in Limited Space Environments NASHVILLE, Tenn.,... Read more.